Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19

Authors

Keywords:

Cloroquina, Arritmias, Covid-19

Downloads

Download data is not yet available.

References

1. Hernández Perera JC, Roque Valdés A, Piñeiro Pérez D. El «desencantamiento» de la cloroquina e hidroxicloroquina frente a la COVID-19. Boletín Científico del Cimeq [Internet]. 2020 [citado 10 enero 2021];22(1):2–6. Disponible en: https://instituciones.sld.cu/bolcimeq/resena-bibliografica/el-desencantamiento-de-la-cloroquina-e-hidroxicloroquina-frente-a-la-covid-19/

2. Medeiros-Domingo A, F Carrasco O, Berni-Betancourt A. Potenciales efectos proarrítmicos de la farmacoterapia contra SARS-CoV-2. Cardiovasc Metab Sci [Internet]. 2020 [citado 10 enero 2021];31(3):2–5. Disponible en: https://www.medigraphic.com/pdfs/cardiovascuar/cms-2020/cmss203h.pdf

3. Barja L, Fitz Maurice M, Chávez González E. Hidroxicloroquina y azitromicina: riesgo cardiovascular, prolongación de QTc y muerte súbita en el nuevo escenario de la pandemia por COVID- 19. CorSalud [Internet]. 2020 [citado 10 enero 2021];12(1):55–58. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/601/1097

4. Sapp J, et al. Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. Can J Cardiol [Internet]. 2020 [citado 10 enero 2021];36(6):948–951. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195336/

5. Silva Borba MG, et al. Efecto de dosis altas versus bajas de difosfato de cloroquina como terapia complementaria para pacientes hospitalizados con infección respiratoria aguda grave por síndrome de Coronavirus 2 (SARS-CoV-2). JAMA Network Open [Internet]. 2020 [citado 10 enero 2021];3(1):4–12. Disponible en: https://es.jamanetwork.com/journals/jamanetworkopen/fullarticle/2765499

6. Gutierrez Lopez A, Cruz Cardentey M, Mengana Betancourt A, Castañeda Chirino O, Martínez López F, Falcón Rodríguez R. Arritmias cardíacas en pacientes con la COVID-19. Escenarios y tratamiento. Can J Cardiol [Internet]. 2020 [citado 10 enero 2021];26(3):2–8. Disponible en: http://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1006/pdf

Downloads

Published

2021-05-24

How to Cite

1.
Salgado-Fuentes CE. Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19. Univ. Méd. Pinareña [Internet]. 2021 May 24 [cited 2025 Apr. 16];18(1):e666. Available from: https://revgaleno.sld.cu/index.php/ump/article/view/666

Issue

Vol. 18 No. 1 (2022): Enero-Abril

Section

Letter to the Editor

License

Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).

Most read articles by the same author(s)